Journal article
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial
Abstract
BACKGROUND: The substantial risk of thrombosis in large coronary artery aneurysms (CAAs) (maximum z-score ≥ 10) after Kawasaki disease (KD) mandates effective thromboprophylaxis. We sought to determine the effectiveness of anticoagulation (low-molecular-weight heparin [LMWH] or warfarin) for thromboprophylaxis in large CAAs.
METHODS: Data from 383 patients enrolled in the International KD Registry (IKDR) were used. Time-to-event analysis was …
Authors
Manlhiot C; Newburger JW; Low T; Dahdah N; Mackie AS; Raghuveer G; Giglia TM; Dallaire F; Mathew M; Runeckles K
Journal
Canadian Journal of Cardiology, Vol. 36, No. 10, pp. 1598–1607
Publisher
Elsevier
Publication Date
October 2020
DOI
10.1016/j.cjca.2020.01.016
ISSN
0828-282X